Jeannette Cany

1.0k total citations
20 papers, 632 citations indexed

About

Jeannette Cany is a scholar working on Immunology, Oncology and Hematology. According to data from OpenAlex, Jeannette Cany has authored 20 papers receiving a total of 632 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Immunology, 9 papers in Oncology and 6 papers in Hematology. Recurrent topics in Jeannette Cany's work include Immune Cell Function and Interaction (13 papers), CAR-T cell therapy research (8 papers) and Immunotherapy and Immune Responses (7 papers). Jeannette Cany is often cited by papers focused on Immune Cell Function and Interaction (13 papers), CAR-T cell therapy research (8 papers) and Immunotherapy and Immune Responses (7 papers). Jeannette Cany collaborates with scholars based in Netherlands, France and United States. Jeannette Cany's co-authors include Harry Dolstra, Joop H. Jansen, Nicolaas Schaap, Sophie Conchon, Janneke S. Hoogstad‐van Evert, Willemijn Hobo, Nicolas Ferry, Anniek B. van der Waart, Vanessa Gauttier and Leon F.A.G. Massuger and has published in prestigious journals such as Blood, PLoS ONE and Journal of Hepatology.

In The Last Decade

Jeannette Cany

20 papers receiving 626 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jeannette Cany Netherlands 15 460 376 119 89 39 20 632
Kathy S. Wang United States 9 360 0.8× 168 0.4× 126 1.1× 125 1.4× 39 1.0× 11 588
Hilde Omholt Norway 6 579 1.3× 384 1.0× 131 1.1× 52 0.6× 37 0.9× 7 689
Efthalia Zervoudi Greece 10 243 0.5× 236 0.6× 172 1.4× 43 0.5× 17 0.4× 10 500
J Woodliff United States 6 121 0.3× 152 0.4× 172 1.4× 197 2.2× 32 0.8× 10 440
Marine Champsaur United States 5 557 1.2× 218 0.6× 114 1.0× 47 0.5× 31 0.8× 5 652
Irene Olivera Spain 12 360 0.8× 259 0.7× 139 1.2× 14 0.2× 55 1.4× 24 544
A Moretta Italy 13 642 1.4× 117 0.3× 84 0.7× 70 0.8× 22 0.6× 15 765
Merel C. M. Strik Netherlands 10 195 0.4× 79 0.2× 154 1.3× 68 0.8× 27 0.7× 10 446
T Hamaoka Japan 10 755 1.6× 411 1.1× 171 1.4× 24 0.3× 78 2.0× 11 901
Kathleen C. Barracchini United States 9 544 1.2× 233 0.6× 206 1.7× 29 0.3× 52 1.3× 11 618

Countries citing papers authored by Jeannette Cany

Since Specialization
Citations

This map shows the geographic impact of Jeannette Cany's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeannette Cany with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeannette Cany more than expected).

Fields of papers citing papers by Jeannette Cany

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeannette Cany. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeannette Cany. The network helps show where Jeannette Cany may publish in the future.

Co-authorship network of co-authors of Jeannette Cany

This figure shows the co-authorship network connecting the top 25 collaborators of Jeannette Cany. A scholar is included among the top collaborators of Jeannette Cany based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeannette Cany. Jeannette Cany is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Evert, Janneke S. Hoogstad‐van, Alan J. Korman, Paul K.J.D. de Jonge, et al.. (2020). TIGIT blockade enhances functionality of peritoneal NK cells with altered expression of DNAM-1/TIGIT/CD96 checkpoint molecules in ovarian cancer. OncoImmunology. 9(1). 1843247–1843247. 54 indexed citations
2.
Guldevall, Karolin, Paul K.J.D. de Jonge, Janneke S. Hoogstad‐van Evert, et al.. (2020). IL-15 superagonist N-803 improves IFNγ production and killing of leukemia and ovarian cancer cells by CD34+ progenitor-derived NK cells. Cancer Immunology Immunotherapy. 70(5). 1305–1321. 33 indexed citations
3.
Mármol, Patricia, et al.. (2019). Evaluating Antibody-Dependent Cell-Mediated Cytotoxicity by Flow Cytometry. Methods in molecular biology. 1913. 181–194. 5 indexed citations
4.
Heskamp, Sandra, Janneke D.M. Molkenboer‐Kuenen, Soley Thordardottir, et al.. (2018). PD-L1 microSPECT/CT Imaging for Longitudinal Monitoring of PD-L1 Expression in Syngeneic and Humanized Mouse Models for Cancer. Cancer Immunology Research. 7(1). 150–161. 30 indexed citations
5.
Evert, Janneke S. Hoogstad‐van, Jeannette Cany, Joop H. Jansen, et al.. (2018). Peritoneal NK cells are responsive to IL-15 and percentages are correlated with outcome in advanced ovarian cancer patients. Oncotarget. 9(78). 34810–34820. 47 indexed citations
6.
Cany, Jeannette, Mieke W.H. Roeven, Janneke S. Hoogstad‐van Evert, et al.. (2017). Decitabine enhances targeting of AML cells by CD34+ progenitor-derived NK cells in NOD/SCID/IL2Rgnull mice. Blood. 131(2). 202–214. 48 indexed citations
7.
Evert, Janneke S. Hoogstad‐van, Jeannette Cany, Roland Brock, et al.. (2017). Umbilical cord blood CD34+progenitor-derived NK cells efficiently kill ovarian cancer spheroids and intraperitoneal tumors in NOD/SCID/IL2Rgnullmice. OncoImmunology. 6(8). e1320630–e1320630. 53 indexed citations
8.
Spanholtz, Jan, Harry Dolstra, Mieke W.H. Roeven, et al.. (2017). Successful transfer of umbilical cord blood CD34 + hematopoietic stem and progenitor-derived NK cells in older acute myeloid leukemia patients. Cytotherapy. 19(5). e5–e6. 1 indexed citations
9.
Roeven, Mieke W.H., Soley Thordardottir, Frans Maas, et al.. (2015). The Aryl Hydrocarbon Receptor Antagonist StemRegenin1 Improves In Vitro Generation of Highly Functional Natural Killer Cells from CD34 + Hematopoietic Stem and Progenitor Cells. Stem Cells and Development. 24(24). 2886–2898. 31 indexed citations
10.
Cany, Jeannette, Anniek B. van der Waart, Jan Spanholtz, et al.. (2015). Combined IL-15 and IL-12 drives the generation of CD34+-derived natural killer cells with superior maturation and alloreactivity potential following adoptive transfer. OncoImmunology. 4(7). e1017701–e1017701. 47 indexed citations
11.
Cany, Jeannette, Harry Dolstra, & Nina Shah. (2015). Umbilical cord blood–derived cellular products for cancer immunotherapy. Cytotherapy. 17(6). 739–748. 23 indexed citations
12.
Copsel, Sabrina, Ariana Bruzzone, María May, et al.. (2014). Multidrug resistance protein 4/ ATP binding cassette transporter 4: a new potential therapeutic target for acute myeloid leukemia. Oncotarget. 5(19). 9308–9321. 28 indexed citations
13.
Thordardottir, Soley, Willemijn Hobo, Anniek B. van der Waart, et al.. (2014). Ex Vivo Generation of Interstitial and Langerhans Cell-like Dendritic Cell Subset–based Vaccines for Hematological Malignancies. Journal of Immunotherapy. 37(5). 267–277. 8 indexed citations
14.
Gauttier, Vanessa, et al.. (2014). Agonistic anti-CD137 antibody treatment leads to antitumor response in mice with liver cancer. International Journal of Cancer. 135(12). 2857–2867. 54 indexed citations
15.
Cany, Jeannette, Anniek B. van der Waart, Marleen Tordoir, et al.. (2013). Natural Killer Cells Generated from Cord Blood Hematopoietic Progenitor Cells Efficiently Target Bone Marrow-Residing Human Leukemia Cells in NOD/SCID/IL2Rgnull Mice. PLoS ONE. 8(6). e64384–e64384. 76 indexed citations
16.
Baril, Patrick, Yann Touchefeu, Jeannette Cany, et al.. (2011). Differential biodistribution of oncolytic poxvirus administered systemically in an autochthonous model of hepatocellular carcinoma. The Journal of Gene Medicine. 13(12). 692–701. 2 indexed citations
17.
Cany, Jeannette, et al.. (2011). Immunotherapy of Hepatocellular Carcinoma: Is there a Place for Regulatory T-Lymphocyte Depletion?. Immunotherapy. 3(sup4). 32–34. 23 indexed citations
18.
Cany, Jeannette, Vanessa Gauttier, Isabelle Archambeaud, et al.. (2010). AFP-specific immunotherapy impairs growth of autochthonous hepatocellular carcinoma in mice. Journal of Hepatology. 54(1). 115–121. 32 indexed citations
19.
McIlroy, Dorian, et al.. (2009). DNA/Amphiphilic Block Copolymer Nanospheres Promote Low-dose DNA Vaccination. Molecular Therapy. 17(8). 1473–1481. 27 indexed citations
20.
Cany, Jeannette, et al.. (2007). A transgenic mouse with β-Galactosidase as a fetal liver self-antigen for immunotherapy studies. Journal of Hepatology. 47(3). 396–403. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kathy S. Wang Breakdown of academic impact, for papers by Hilde Omholt Breakdown of academic impact, for papers by Efthalia Zervoudi Breakdown of academic impact, for papers by J Woodliff Breakdown of academic impact, for papers by Marine Champsaur Breakdown of academic impact, for papers by Irene Olivera Breakdown of academic impact, for papers by A Moretta Breakdown of academic impact, for papers by Merel C. M. Strik Breakdown of academic impact, for papers by T Hamaoka Breakdown of academic impact, for papers by Kathleen C. Barracchini
Rankless by CCL
2026